Cerebrospinal Fluid and Behavioral Changes After Methyltestosterone Administration

Abstract
ANABOLIC ANDROGENIC steroid (AAS) abuse poses a significant public health problem and has been associated with a range of psychiatric symptoms, including psychosis,1 irritability and aggression,2 and major mood syndromes.3 In a previous study of normal men,4 we demonstrated that even short-term administration of the AAS methyltestosterone (MT) produced significant mood and behavioral symptoms. Two subsequent blind, placebo-controlled studies5,6 confirmed the ability of such steroids to induce mood and behavioral symptoms in both normal volunteers and AAS users. The mechanisms underlying the development of AAS-induced psychiatric symptoms remain largely undetermined.

This publication has 1 reference indexed in Scilit: